Director Market Access Strategy, New Products & Business Development, Solid Tumor

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Market Access

Job Sub Function:
Health Economics Market Access

Job Category:
Professional

All Job Posting Locations:
Horsham, Pennsylvania, United States of America, Titusville, New Jersey, United States of America

Job Description:

Johnson & Johnson Health Care Systems Inc.

(Strategic Customer Group, SCG) is recruiting for a Director of Market Access Strategy for New Products & Business Development (NP&BD) Solid Tumor.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.

Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

The Director will help to shape Johnson & Johnson’s scientific pipeline by optimizing for greater access when these therapies launch.

This is a key role on SCG Value, Access, and Pricing (VAP) team which will integrate key capabilities in the early pipeline to shape success with Market Access (MA) customers in the U.S.

market.

Given the increasing complexity of the Access environment, the advanced compounds in the Janssen pipeline and the active business development environment, there are critical decisions made early that shape commercial success of compounds.

These disruptive innovations require rethinking of value articulation and new considerations on how therapies fit within systems of care.

This position will be a key member of the cross-functional U.S.

Integrated Strategy Team (IST) which includes NP&BD, Medical, Brand, and Value & Evidence teams.

Director will advise on all pipeline compounds, line extensions, and indication expansions from Discovery through Phase 3 development and label submission.

You will integrate a Market Access perspective into key pipeline decisions to support optimal payer coverage and patient access for new pipeline products when in market.


* Serve as a key member of U.S.

Integrated Strategy Team and collaborate with Global teams for assigned TA to shape pipeline compound strategy and inform stage gate decisions


* Generate insights to shape evidence strategy for the compound


* Assess & advise clinical, economic, humanistic evidence strategy to shape early value proposition and commercial plans from an Access perspective
...